Cipher Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 6.5%.

Top 12 shareholders own 44.79% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
37.4%	John Mull	9,566,150	US$87.5m	0%	no data
3.19%	Craig Mull	817,149	US$7.5m	13.6%	no data
1.43%	Harold Wolkin	366,799	US$3.4m	0.4%	no data
0.98%	Arthur Deboeck	251,540	US$2.3m	0%	no data
0.88%	Huber Capital Management LLC	224,700	US$2.1m	0%	0.47%
0.41%	Dimensional Fund Advisors LP	105,454	US$964.2k	1.14%	no data
0.33%	Diane Gajewczyk	84,036	US$768.3k	0%	no data
0.059%	Maxam Capital Management Ltd.	15,000	US$137.2k	0%	0.24%
0.051%	StoneCastle Investment Management Inc.	12,970	US$118.6k	0%	1.46%
0.034%	Tralucent Asset Management Inc	8,817	US$80.6k	0%	0.19%
0.02%	Cathy Steiner	5,000	US$45.7k	0%	no data
0.02%	Bryan Jacobs	5,000	US$45.7k	0%	no data